Angela Skelton

1.3k total citations
20 papers, 754 citations indexed

About

Angela Skelton is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Angela Skelton has authored 20 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 10 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Angela Skelton's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (7 papers) and HIV/AIDS drug development and treatment (5 papers). Angela Skelton is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (7 papers) and HIV/AIDS drug development and treatment (5 papers). Angela Skelton collaborates with scholars based in United States, United Kingdom and China. Angela Skelton's co-authors include Robert A. Chase, Jacquelyn Wright-Minogue, Xinchun Tong, B. R. Malcolm, Tong Chen, Viyyoor Girijavallabhan, F. George Njoroge, Andrew Prongay, Ellen Xia and Stéphane Bogen and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Virology.

In The Last Decade

Angela Skelton

18 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Skelton United States 13 492 421 373 158 121 20 754
Rachel Trowbridge Australia 16 340 0.7× 308 0.7× 121 0.3× 77 0.5× 182 1.5× 26 691
Karen Rigat United States 10 363 0.7× 262 0.6× 193 0.5× 66 0.4× 115 1.0× 13 511
Hangchun Zhang United States 5 275 0.6× 131 0.3× 166 0.4× 242 1.5× 197 1.6× 7 501
Frederick Lahser United States 16 336 0.7× 266 0.6× 197 0.5× 140 0.9× 154 1.3× 27 621
Robert J. Carrick United States 13 459 0.9× 524 1.2× 186 0.5× 52 0.3× 128 1.1× 14 806
Hyunsoon Kang United States 9 649 1.3× 495 1.2× 451 1.2× 33 0.2× 173 1.4× 11 795
Carolyn A. Luscombe Australia 15 290 0.6× 434 1.0× 260 0.7× 42 0.3× 76 0.6× 24 628
D. Genovese Italy 16 244 0.5× 260 0.6× 192 0.5× 142 0.9× 51 0.4× 23 489
D.C. Pevear United States 7 93 0.2× 227 0.5× 173 0.5× 200 1.3× 96 0.8× 9 429
J C Pugh United States 16 556 1.1× 877 2.1× 358 1.0× 57 0.4× 193 1.6× 23 1.1k

Countries citing papers authored by Angela Skelton

Since Specialization
Citations

This map shows the geographic impact of Angela Skelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Skelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Skelton more than expected).

Fields of papers citing papers by Angela Skelton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Skelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Skelton. The network helps show where Angela Skelton may publish in the future.

Co-authorship network of co-authors of Angela Skelton

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Skelton. A scholar is included among the top collaborators of Angela Skelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Skelton. Angela Skelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tong, Xiao, Ashok Arasappan, Frank Bennett, et al.. (2010). Preclinical Characterization of the Antiviral Activity of SCH 900518 (Narlaprevir), a Novel Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease. Antimicrobial Agents and Chemotherapy. 54(6). 2365–2370. 30 indexed citations
3.
Qiu, Ping, Stephanie Curry, Zhiyong Guo, et al.. (2009). Identification of HCV protease inhibitor resistance mutations by selection pressure-based method. Nucleic Acids Research. 37(10). e74–e74. 36 indexed citations
4.
Chase, Robert A., Angela Skelton, Ellen Xia, et al.. (2009). A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors. Antiviral Research. 84(2). 178–184. 14 indexed citations
5.
Tong, Xiao, Ashok Arasappan, Frank Bennett, et al.. (2009). 967 PRECLINICAL CHARACTERIZATION OF SCH 900518, A NOVEL MECHANISM-BASED INHIBITOR OF HCV NS3 PROTEASE. Journal of Hepatology. 50. S351–S351.
6.
Tong, Xinchun, Stéphane Bogen, Robert A. Chase, et al.. (2008). Characterization of resistance mutations against HCV ketoamide protease inhibitors. Antiviral Research. 77(3). 177–185. 100 indexed citations
7.
8.
Howe, Anita Y. M., Robert Ralston, Robert A. Chase, et al.. (2007). [432] FAVORABLE CROSS-RESISTANCE PROFILE OF TWO NOVEL HEPATITIS C VIRUS INHIBITORS, SCH-503034 AND HCV-796, AND ENHANCED ANTI-REPLICON ACTIVITY MEDIATED BY THE COMBINED USE OF BOTH COMPOUNDS. Journal of Hepatology. 46. S165–S165. 5 indexed citations
9.
Tong, Xinchun, Robert A. Chase, Angela Skelton, et al.. (2006). Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034. Antiviral Research. 70(2). 28–38. 184 indexed citations
10.
Yi, MinKyung, Xiao Tong, Angela Skelton, et al.. (2005). Mutations Conferring Resistance to SCH6, a Novel Hepatitis C Virus NS3/4A Protease Inhibitor. Journal of Biological Chemistry. 281(12). 8205–8215. 86 indexed citations
11.
O’Connell, Juliette, Stuart Cox, Peter Buontempo, et al.. (2003). Primary Human Hepatocyte Culture for the Study of HCV. Humana Press eBooks. 19. 495–500. 1 indexed citations
12.
Lahser, Frederick, Jacquelyn Wright-Minogue, Angela Skelton, & Bruce A. Malcolm. (2003). Quantitative Estimation of Viral Fitness Using Pyrosequencing™. BioTechniques. 34(1). 26–28. 12 indexed citations
13.
Lai, Vicky C. H., Weidong Zhong, Angela Skelton, et al.. (2000). Generation and Characterization of a Hepatitis C Virus NS3 Protease-Dependent Bovine Viral Diarrhea Virus. Journal of Virology. 74(14). 6339–6347. 29 indexed citations
14.
Hong, Zhi, Robert E. Lanford, Bernadette Guerra, et al.. (1999). Generation of Transmissible Hepatitis C Virions from a Molecular Clone in Chimpanzees. Virology. 256(1). 36–44. 44 indexed citations
15.
Zhong, Weidong, Paul Ingravallo, Jacquelyn Wright-Minogue, et al.. (1999). Nucleoside Triphosphatase and RNA Helicase Activities Associated with GB Virus B Nonstructural Protein 3. Virology. 261(2). 216–226. 19 indexed citations
16.
Buontempo, Peter, Stuart Cox, Jacquelyn Wright-Minogue, et al.. (1997). SCH 48973: a potent, broad-spectrum, antienterovirus compound. Antimicrobial Agents and Chemotherapy. 41(6). 1220–1225. 45 indexed citations
17.
Chase, Robert A., Eric Ferrari, Angela Skelton, et al.. (1997). SCH 43478 and analogs: in vitro activity and in vivo efficacy of novel agents for herpesvirus type 2. Antiviral Research. 35(3). 139–146. 27 indexed citations
18.
19.
Cox, Stuart, Peter Buontempo, Jacquelyn Wright-Minogue, et al.. (1996). Antipicornavirus activity of SCH 47802 and analogs: in vitro and in vivo studies. Antiviral Research. 32(2). 71–79. 22 indexed citations
20.
DuHamel, Thomas R., et al.. (1974). Early Parental Perceptions and The High Risk Neonate. Clinical Pediatrics. 13(12). 1052–1056. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel Trowbridge Breakdown of academic impact, for papers by Karen Rigat Breakdown of academic impact, for papers by Hangchun Zhang Breakdown of academic impact, for papers by Frederick Lahser Breakdown of academic impact, for papers by Robert J. Carrick Breakdown of academic impact, for papers by Hyunsoon Kang Breakdown of academic impact, for papers by Carolyn A. Luscombe Breakdown of academic impact, for papers by D. Genovese Breakdown of academic impact, for papers by D.C. Pevear Breakdown of academic impact, for papers by J C Pugh
Rankless by CCL
2026